EXELIXIS, INC.
EXEL · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Beckerle Mary C: Form 4
Insider disclosure · Filed · Report period 10 Aug 2026
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- EXEL · 30161Q104 - Common Stock, par value $0.001 per share (the "Shares")
Company details and SEC sources
CIK 0000939767 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- EXEL on Nasdaq
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 1851 Harbor Bay Parkway, Alameda, CA, 94502
- Incorporated in
- DE
- Fiscal year end
- 01 January
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields